Callie Fredlender

517 total citations
6 papers, 167 citations indexed

About

Callie Fredlender is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Callie Fredlender has authored 6 papers receiving a total of 167 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Cellular and Molecular Neuroscience and 1 paper in Neurology. Recurrent topics in Callie Fredlender's work include Pluripotent Stem Cells Research (2 papers), Ubiquitin and proteasome pathways (2 papers) and Protein Degradation and Inhibitors (2 papers). Callie Fredlender is often cited by papers focused on Pluripotent Stem Cells Research (2 papers), Ubiquitin and proteasome pathways (2 papers) and Protein Degradation and Inhibitors (2 papers). Callie Fredlender collaborates with scholars based in United States. Callie Fredlender's co-authors include Michelle Skime, Richard M. Weinshilboum, Kelly J. Heard, Krishna C. Vadodaria, Amy Le, Yuan Ji, Fred H. Gage, Daniel K. Hall‐Flavin, Timothy J. Nelson and Apuã C.M. Paquola and has published in prestigious journals such as Nature Chemical Biology, Molecular Psychiatry and Translational Psychiatry.

In The Last Decade

Callie Fredlender

6 papers receiving 165 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Callie Fredlender United States	4	96	46	41	28	23	6	167
Rainer Stoffel Germany	7	50 0.5×	32 0.7×	37 0.9×	67 2.4×	9 0.4×	9	175
Katja Weckmann Germany	5	78 0.8×	32 0.7×	108 2.6×	33 1.2×	5 0.2×	6	200
Jiaquan Liang China	9	55 0.6×	9 0.2×	42 1.0×	17 0.6×	7 0.3×	45	218
Ann‐Marie Waldron Belgium	9	58 0.6×	47 1.0×	90 2.2×	51 1.8×	7 0.3×	15	269
Rixing Lin Canada	7	82 0.9×	20 0.4×	52 1.3×	22 0.8×	2 0.1×	11	163
Evgeniy Svirin Russia	9	45 0.5×	53 1.2×	39 1.0×	41 1.5×	5 0.2×	25	201
Wendy Feng United States	7	77 0.8×	77 1.7×	26 0.6×	20 0.7×	3 0.1×	10	288
Adrina Kocharian United States	8	93 1.0×	188 4.1×	23 0.6×	56 2.0×	4 0.2×	11	293
Jackie Ngai-Man Chan Hong Kong	7	42 0.4×	30 0.7×	14 0.3×	17 0.6×	3 0.1×	10	174
Karen S. Rommelfanger United States	6	64 0.7×	145 3.2×	14 0.3×	16 0.6×	5 0.2×	7	218

Countries citing papers authored by Callie Fredlender

Since Specialization

Citations

This map shows the geographic impact of Callie Fredlender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Callie Fredlender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Callie Fredlender more than expected).

Fields of papers citing papers by Callie Fredlender

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Callie Fredlender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Callie Fredlender. The network helps show where Callie Fredlender may publish in the future.

Co-authorship network of co-authors of Callie Fredlender

This figure shows the co-authorship network connecting the top 25 collaborators of Callie Fredlender. A scholar is included among the top collaborators of Callie Fredlender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Callie Fredlender. Callie Fredlender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Fredlender, Callie, Jan Zimak, Richard Watson, et al.. (2024). Methylarginine targeting chimeras for lysosomal degradation of intracellular proteins. Nature Chemical Biology. 20(12). 1566–1576. 14 indexed citations

2.

Fredlender, Callie, Samantha R. Levine, Jan Zimak, & Robert C. Spitale. (2022). Repurposing a DNA‐Repair Enzyme for Targeted Protein Degradation. ChemBioChem. 23(19). e202200053–e202200053. 1 indexed citations

3.

Heard, Kelly J., Maxim N. Shokhirev, Callie Fredlender, et al.. (2021). Chronic cortisol differentially impacts stem cell-derived astrocytes from major depressive disorder patients. Translational Psychiatry. 11(1). 608–608. 24 indexed citations

4.

Vadodaria, Krishna C., Yuan Ji, Michelle Skime, et al.. (2019). Altered serotonergic circuitry in SSRI-resistant major depressive disorder patient-derived neurons. Molecular Psychiatry. 24(6). 808–818. 70 indexed citations

5.

Vadodaria, Krishna C., Yuan Ji, Michelle Skime, et al.. (2019). Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons. Molecular Psychiatry. 24(6). 795–807. 57 indexed citations

6.

Vadodaria, Krishna C., Yuan Ji, Michelle Skime, et al.. (2019). Studying treatment resistance in depression using patient derived neurons in vitro. Molecular Psychiatry. 24(6). 775–775. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact